Blood Clotting Factor VIII: From Evolution to Therapy
Recombinant blood clotting factor VIII is one of the most complex proteins for industrial manufacturing due to the low efficiency of its gene transcription, massive intracellular loss of its proprotein during post-translational processing, and the instability of the secreted protein. Improvement in hemophilia A therapy requires a steady increase in the production of factor VIII drugs despite tightening standards of product quality and viral safety. More efficient systems for heterologous expression of factor VIII can be created on the basis of the discovered properties of its gene transcription, post-translational processing, and behavior in the bloodstream. The present review describes the deletion variants of factor VIII protein with increased secretion efficiency and the prospects for the pharmaceutical development of longer acting variants and derivatives of factor VIII.
Citations by journals
Citations by publishers
1
2
3
4
5
6
7
|
|
Elsevier
|
Elsevier
7 publications, 17.95%
|
Wiley
|
Wiley
7 publications, 17.95%
|
Pleiades Publishing
|
Pleiades Publishing
3 publications, 7.69%
|
Frontiers Media S.A.
|
Frontiers Media S.A.
3 publications, 7.69%
|
Springer Nature
|
Springer Nature
3 publications, 7.69%
|
Taylor & Francis
|
Taylor & Francis
3 publications, 7.69%
|
SAGE
|
SAGE
2 publications, 5.13%
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 5.13%
|
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP)
|
Scientific Center for Expert Evaluation of Medicinal Products (SCEEMP)
2 publications, 5.13%
|
Wolters Kluwer Health
|
Wolters Kluwer Health
1 publication, 2.56%
|
Bentham Science
|
Bentham Science
1 publication, 2.56%
|
Public Library of Science (PLoS)
|
Public Library of Science (PLoS)
1 publication, 2.56%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
1 publication, 2.56%
|
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
|
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications), 1, 2.56%
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
1 publication, 2.56%
|
1
2
3
4
5
6
7
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.